{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:13:24Z","timestamp":1772021604173,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04225-6","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:33:05Z","timestamp":1769851985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival prognosis and influencing factors in elderly patients with stage I-III breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Yaling","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihui","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"3","key":"4225_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4225_CR2","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/S2666-7568(21)00280-4","volume":"3","author":"N Carleton","year":"2022","unstructured":"Carleton N, Nasrazadani A, Gade K, et al. Personalizing therapy for early-stage Estrogen receptor-positive breast cancer in older women. Lancet Healthy Longev. 2022;3(1):e54\u201366. https:\/\/doi.org\/10.1016\/S2666-7568(21)00280-4.","journal-title":"Lancet Healthy Longev"},{"issue":"3","key":"4225_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10549-024-07280-3","volume":"205","author":"YT Teng","year":"2024","unstructured":"Teng YT, Wang YA, Dong YH, Liu JJ. Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics. Breast Cancer Res Treat. 2024;205(3):619\u201331. https:\/\/doi.org\/10.1007\/s10549-024-07280-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"4225_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.285.7.885","volume":"285","author":"R Yancik","year":"2001","unstructured":"Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885\u201392. https:\/\/doi.org\/10.1001\/jama.285.7.885.","journal-title":"JAMA"},{"issue":"10","key":"4225_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.41152","volume":"7","author":"CA Minami","year":"2024","unstructured":"Minami CA, Dey T, Chen YJ, et al. Regional variation in deescalated therapy in older adults with early-stage breast cancer. JAMA Netw Open. 2024;7(10):e2441152. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.41152.","journal-title":"JAMA Netw Open"},{"key":"4225_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.578880","volume":"11","author":"Y Peng","year":"2021","unstructured":"Peng Y, Hu T, Cheng L, et al. Evaluating and balancing the risk of breast cancer-specific death and other cause-specific death in elderly breast cancer patients. Front Oncol. 2021;11:578880. https:\/\/doi.org\/10.3389\/fonc.2021.578880.","journal-title":"Front Oncol"},{"key":"4225_CR7","doi-asserted-by":"publisher","unstructured":"Karabulut Gul S, Tepetam H, Benli Yavuz B et al. Multicenter study on breast cancer in the geriatric population: insights for effective treatment Strategies.Cureus.2024;16(3):e57253.Published 2024 Mar 30. https:\/\/doi.org\/10.7759\/cureus.57253","DOI":"10.7759\/cureus.57253"},{"issue":"7","key":"4225_CR8","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S1470-2045(20)30741-5","volume":"22","author":"L Biganzoli","year":"2021","unstructured":"Biganzoli L, Battisti NML, Wildiers H, et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol. 2021;22(7):e327\u201340. https:\/\/doi.org\/10.1016\/S1470-2045(20)30741-5.","journal-title":"Lancet Oncol"},{"issue":"20","key":"4225_CR9","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa0810266","volume":"360","author":"HB Muss","year":"2009","unstructured":"Muss HB, Berry DA, Cirrincione CT, et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009;360(20):2055\u201365. https:\/\/doi.org\/10.1056\/NEJMoa0810266.","journal-title":"N Engl J Med"},{"issue":"1","key":"4225_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1634\/theoncologist.2018-0076","volume":"24","author":"CP Williams","year":"2019","unstructured":"Williams CP, Kenzik KM, Azuero A, et al. Impact of guideline-discordant treatment on cost and health care utilization in older adults with early-stage breast cancer. Oncologist. 2019;24(1):31\u20137. https:\/\/doi.org\/10.1634\/theoncologist.2018-0076.","journal-title":"Oncologist"},{"issue":"19","key":"4225_CR11","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1200\/JCO.2003.02.046","volume":"21","author":"C Bouchardy","year":"2003","unstructured":"Bouchardy C, Rapiti E, Fioretta G, et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003;21(19):3580\u20137. https:\/\/doi.org\/10.1200\/JCO.2003.02.046.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4225_CR12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1245\/s10434-023-14446-8","volume":"31","author":"CA Minami","year":"2024","unstructured":"Minami CA, Jin G, Freedman RA, Schonberg MA, King TA, Mittendorf EA. Trends in locoregional therapy in older women with early-stage hormone receptor-positive breast cancer by frailty and life expectancy. Ann Surg Oncol. 2024;31(2):920\u201330. https:\/\/doi.org\/10.1245\/s10434-023-14446-8.","journal-title":"Ann Surg Oncol"},{"key":"4225_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.breast.2022.09.001","volume":"66","author":"Y Sang","year":"2022","unstructured":"Sang Y, Yang B, Mo M, et al. Treatment and survival outcomes in older women with primary breast cancer: a retrospective propensity score-matched analysis. Breast. 2022;66:24\u201330. https:\/\/doi.org\/10.1016\/j.breast.2022.09.001.","journal-title":"Breast"},{"key":"4225_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2147\/BCTT.S537429","volume":"17","author":"X Aimaiti","year":"2025","unstructured":"Aimaiti X, Wang Y, Ismtula D, et al. Bystin is a prognosis and immune biomarker: from Pan-Cancer analysis to validation in breast cancer. Breast Cancer (Dove Med Press). 2025;17:755\u201379. https:\/\/doi.org\/10.2147\/BCTT.S537429. Published 2025 Aug 29.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"4225_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1670526","volume":"15","author":"D Elihamu","year":"2025","unstructured":"Elihamu D, Li Y, Wang Y, et al. CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation. Front Oncol. 2025;15:1670526. https:\/\/doi.org\/10.3389\/fonc.2025.1670526.","journal-title":"Front Oncol"},{"key":"4225_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1667589","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Wang Y, Ma H, et al. CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front Oncol. 2025;15:1667589. https:\/\/doi.org\/10.3389\/fonc.2025.1667589.","journal-title":"Front Oncol"},{"issue":"2","key":"4225_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.21037\/tcr-24-1291","volume":"14","author":"Y Jing","year":"2025","unstructured":"Jing Y, Wang Y, Li Y, et al. Diagnostics and immunological function of CENPN in human tumors: from pan-cancer analysis to validation in breast cancer. Transl Cancer Res. 2025;14(2):881\u2013906. https:\/\/doi.org\/10.21037\/tcr-24-1291.","journal-title":"Transl Cancer Res"},{"issue":"12","key":"4225_CR18","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1200\/JCO.2009.25.9796","volume":"28","author":"MA Schonberg","year":"2010","unstructured":"Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among the oldest old: tumour characteristics, treatment choices, and survival. J Clin Oncol. 2010;28(12):2038\u201345. https:\/\/doi.org\/10.1200\/JCO.2009.25.9796.","journal-title":"J Clin Oncol"},{"issue":"7","key":"4225_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/jnci\/92.7.550","volume":"92","author":"SG Diab","year":"2000","unstructured":"Diab SG, Elledge RM, Clark GM. Tumour characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000;92(7):550\u20136. https:\/\/doi.org\/10.1093\/jnci\/92.7.550.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"4225_CR20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/ijc.31950","volume":"144","author":"ALV Johansson","year":"2019","unstructured":"Johansson ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, Johannesen TB, Ursin G. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer. 2019;144(6):1251\u201361. https:\/\/doi.org\/10.1002\/ijc.31950.","journal-title":"Int J Cancer"},{"issue":"2","key":"4225_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.6004\/jnccn.2009.0016","volume":"7","author":"H Klepin","year":"2009","unstructured":"Klepin H, Mohile S, Hurria A. Geriatric assessment in older patients with breast cancer. J Natl Compr Canc Netw. 2009;7(2):226\u201336. https:\/\/doi.org\/10.6004\/jnccn.2009.0016.","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"4225_CR22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/sj.bjc.6603709","volume":"96","author":"K Lavelle","year":"2007","unstructured":"Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women\u2009>\u2009or =\u200965 years. Br J Cancer. 2007;96(8):1197\u2013203. https:\/\/doi.org\/10.1038\/sj.bjc.6603709.","journal-title":"Br J Cancer"},{"key":"4225_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/DDDT.S336643","volume":"16","author":"Z Li","year":"2022","unstructured":"Li Z, Wei H, Li S, Wu P, Mao X. The role of progesterone receptors in breast cancer. Drug Des Devel Ther. 2022;16:305\u201314. https:\/\/doi.org\/10.2147\/DDDT.S336643.","journal-title":"Drug Des Devel Ther"},{"issue":"7560","key":"4225_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature14583","volume":"523","author":"H Mohammed","year":"2015","unstructured":"Mohammed H, Russell IA, Stark R, et al. Progesterone receptor modulates ER\u03b1 action in breast cancer. Nature. 2015;523(7560):313\u20137. https:\/\/doi.org\/10.1038\/nature14583.","journal-title":"Nature"},{"issue":"4","key":"4225_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3645","volume":"3","author":"B Trabert","year":"2020","unstructured":"Trabert B, Bauer DC, Buist DSM, et al. Association of circulating progesterone with breast cancer risk among postmenopausal women. JAMA Netw Open. 2020;3(4):e203645. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3645.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4225_CR26","doi-asserted-by":"publisher","first-page":"T49","DOI":"10.1530\/JME-20-0104","volume":"65","author":"KB Horwitz","year":"2020","unstructured":"Horwitz KB, Sartorius CA. 90 YEARS OF PROGESTERONE: progesterone and progesterone receptors in breast cancer: past, present, future. J Mol Endocrinol. 2020;65(1):T49\u201363. https:\/\/doi.org\/10.1530\/JME-20-0104.","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"4225_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12282-023-01538-2","volume":"31","author":"W Ding","year":"2024","unstructured":"Ding W, Ye D, Chen H, Lin Y, Li Z, Tu C. Clinicopathological differences and survival benefit in ER+\/. Breast Cancer. 2024;31(2):295\u2013304. https:\/\/doi.org\/10.1007\/s12282-023-01538-2. PR+\/HER2\u2009+\u2009vs ER+\/PR-\/HER2\u2009+\u2009breast cancer subtypes.","journal-title":"Breast Cancer"},{"issue":"8","key":"4225_CR28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/cncr.21805","volume":"106","author":"DB Kopans","year":"2006","unstructured":"Kopans DB. The effect of changes in tumour size on breast carcinoma survival in the U.S.: 1975\u20131999. Cancer. 2006;106(8):1863\u20134. https:\/\/doi.org\/10.1002\/cncr.21805.","journal-title":"Cancer"},{"issue":"7","key":"4225_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.bjc.6603668","volume":"96","author":"LM Woods","year":"2007","unstructured":"Woods LM, Rachet B, Cooper N, Coleman MP. Predicted trends in long-term breast cancer survival in England and Wales. Br J Cancer. 2007;96(7):1135\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6603668.","journal-title":"Br J Cancer"},{"key":"4225_CR30","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review, 1975-2018. Bethesda: National Cancer Institute; 2021. Based on November 2020 SEER data submission. https:\/\/seer.cancer.gov\/csr\/1975_2018\/."},{"issue":"1","key":"4225_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1245\/s10434-010-1217-7","volume":"18","author":"G Martelli","year":"2011","unstructured":"Martelli G, Miceli R, Daidone MG, et al. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol. 2011;18(1):125\u201333. https:\/\/doi.org\/10.1245\/s10434-010-1217-7.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4225_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello G, Gatza ML, Beck AH, et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 2015;163(2):506\u201319. https:\/\/doi.org\/10.1016\/j.cell.2015.09.033.","journal-title":"Cell"},{"issue":"10","key":"4225_CR33","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101(10):736\u201350. https:\/\/doi.org\/10.1093\/jnci\/djp082.","journal-title":"J Natl Cancer Inst"},{"key":"4225_CR34","doi-asserted-by":"publisher","unstructured":"de Azambuja E, Cardoso F, de Castro G Jr, et al. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer. 2007;96(10):1504\u201313. https:\/\/doi.org\/10.1038\/sj.bjc.6603756.","DOI":"10.1038\/sj.bjc.6603756"},{"issue":"2","key":"4225_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","volume":"11","author":"R Yerushalmi","year":"2010","unstructured":"Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11(2):174\u201383. https:\/\/doi.org\/10.1016\/S1470-2045(09)70262-1.","journal-title":"Lancet Oncol"},{"issue":"5","key":"4225_CR36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3892\/etm.2010.133","volume":"1","author":"R Nishimura","year":"2010","unstructured":"Nishimura R, Osako T, Okumura Y, Hayashi M, Toyozumi Y, Arima N. Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer. Exp Ther Med. 2010;1(5):747\u201354. https:\/\/doi.org\/10.3892\/etm.2010.133.","journal-title":"Exp Ther Med"},{"key":"4225_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2407-13-15","volume":"13","author":"A Crispo","year":"2013","unstructured":"Crispo A, Barba M, D\u2019Aiuto G, et al. Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series. BMC Cancer. 2013;13:15. https:\/\/doi.org\/10.1186\/1471-2407-13-15. Published 2013 Jan 10.","journal-title":"BMC Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04225-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04225-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04225-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:30:46Z","timestamp":1772019046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04225-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4225"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04225-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Sichuan Cancer Hospital on February 28, 2023. (Ethical Approval Number: SCCHEC-02-2023-030).Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}